147 related articles for article (PubMed ID: 36103974)
21. Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets.
Rohatgi N; Aly H; Marshall CA; McDonald WG; Kletzien RF; Colca JR; McDaniel ML
PLoS One; 2013; 8(5):e62012. PubMed ID: 23650507
[TBL] [Abstract][Full Text] [Related]
22. Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.
Choi JH; Banks AS; Kamenecka TM; Busby SA; Chalmers MJ; Kumar N; Kuruvilla DS; Shin Y; He Y; Bruning JB; Marciano DP; Cameron MD; Laznik D; Jurczak MJ; Schürer SC; Vidović D; Shulman GI; Spiegelman BM; Griffin PR
Nature; 2011 Sep; 477(7365):477-81. PubMed ID: 21892191
[TBL] [Abstract][Full Text] [Related]
23. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
24. β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.
Rahman S; Czernik PJ; Lu Y; Lecka-Czernik B
PLoS One; 2012; 7(12):e51746. PubMed ID: 23272157
[TBL] [Abstract][Full Text] [Related]
25. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.
Crossno JT; Majka SM; Grazia T; Gill RG; Klemm DJ
J Clin Invest; 2006 Dec; 116(12):3220-8. PubMed ID: 17143331
[TBL] [Abstract][Full Text] [Related]
27. Impact of pioglitazone on bone mineral density and bone marrow fat content.
Pop LM; Lingvay I; Yuan Q; Li X; Adams-Huet B; Maalouf NM
Osteoporos Int; 2017 Nov; 28(11):3261-3269. PubMed ID: 28735463
[TBL] [Abstract][Full Text] [Related]
28. Thiazolidinedione-induced lipid droplet formation during osteogenic differentiation.
van de Vyver M; Andrag E; Cockburn IL; Ferris WF
J Endocrinol; 2014 Nov; 223(2):119-32. PubMed ID: 25210048
[TBL] [Abstract][Full Text] [Related]
29. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
[TBL] [Abstract][Full Text] [Related]
30. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
Lee MA; Tan L; Yang H; Im YG; Im YJ
Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
[TBL] [Abstract][Full Text] [Related]
31. Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression.
Han YS; Kim SM; Lee JH; Lee SH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734669
[TBL] [Abstract][Full Text] [Related]
32. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.
Cipolletta D; Feuerer M; Li A; Kamei N; Lee J; Shoelson SE; Benoist C; Mathis D
Nature; 2012 Jun; 486(7404):549-53. PubMed ID: 22722857
[TBL] [Abstract][Full Text] [Related]
33. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes.
Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS
PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
35. Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.
Rippo MR; Babini L; Prattichizzo F; Graciotti L; Fulgenzi G; Tomassoni Ardori F; Olivieri F; Borghetti G; Cinti S; Poloni A; Fazioli F; Procopio AD
Cell Death Dis; 2013 Apr; 4(4):e594. PubMed ID: 23598406
[TBL] [Abstract][Full Text] [Related]
36. Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.
Kanda S; Nakashima R; Takahashi K; Tanaka J; Ogawa J; Ogata T; Yachi M; Araki K; Ohsumi J
J Pharmacol Sci; 2009 Oct; 111(2):155-66. PubMed ID: 19809220
[TBL] [Abstract][Full Text] [Related]
37. Effect of the antidiabetic agent pioglitazone on bone metabolism in rats.
Kanda J; Izumo N; Kobayashi Y; Onodera K; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
J Pharmacol Sci; 2017 Sep; 135(1):22-28. PubMed ID: 28928054
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone increases gallbladder volume in insulin-resistant obese mice.
Al-Azzawi HH; Mathur A; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
J Surg Res; 2006 Dec; 136(2):192-7. PubMed ID: 17045610
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist.
Kanda Y; Shimoda M; Hamamoto S; Tawaramoto K; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E278-86. PubMed ID: 19920213
[TBL] [Abstract][Full Text] [Related]
40. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
Higashi Y; Holder K; Delafontaine P
J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
